Morningstar Investor users sign in here.

Company Profile

  • Business description

    Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications.

  • Contact

    1700 Owens Street
    Suite 205
    San Francisco CA 94158
    USA

    T: +1 415 660-5320

    E: IR@nurixtx.com

    http://www.nurixtx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    30 November 2024

    Employees

    284

Stocks News & Analysis

stocks

A 15 step checklist from Buffett's forgotten inspiration

Phil Fisher achieved remarkable stock market returns by holding high quality growth companies for long periods of time. Here's how he found them.
video

Are Guzman's growth targets realistic?

Morningstar Equity Analyst Lochlan Halloway discusses Guzman's upcoming IPO. 
stocks

Apple: Generative AI strategy should drive sales and upgrades

We were pleased with the newly announced Apple Intelligence suite of features.

Markets

Index
Last price
Change
% Change
All Ordinaries 7,974.80 27.70 -0.35%
CAC 40 7,503.27 204.75 -2.66%
DAX 40 18,002.02 263.66 -1.44%
Dow JONES (US) 38,589.16 57.94 -0.15%
FTSE 100 8,146.86 16.81 -0.21%
HKSE 17,941.78 170.85 -0.94%
NASDAQ 17,688.88 21.32 0.12%
Nikkei 225 38,814.56 94.09 0.24%
NZX 50 Index 11,864.89 7.75 -0.07%
S&P 500 5,431.60 2.14 -0.04%
S&P/ASX 200 7,724.30 25.40 -0.33%
SSE Composite Index 3,032.63 3.71 0.12%

Market Movers

Name
Last price
Change
% Change
Pilbara Minerals Ltd PLS 3.24 0.08 -2.41%
Peninsula Energy Ltd PEN 0.11 0.01 5.00%
Sayona Mining Ltd SYA 0.04 0.00 -2.70%
Zip Co Ltd ZIP 1.45 0.14 10.27%
Orora Ltd ORA 1.96 0.10 -4.63%
South32 Ltd S32 3.66 0.02 0.55%
Tabcorp Holdings Ltd TAH 0.66 0.06 10.08%
Adbri Ltd ABC 3.19 0.00 0.00%
Resolute Mining Ltd RSG 0.51 0.04 -7.27%
Core Lithium Ltd CXO 0.09 0.00 -2.13%